Miltefosine--discovery of the antileishmanial activity of phospholipid derivatives.
about
Bioactivity of miltefosine against aquatic stages of Schistosoma mansoni, Schistosoma haematobium and their snail hosts, supported by scanning electron microscopyMiltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidence-based treatment recommendationsMiltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasisAdvancing drug innovation for neglected diseases-criteria for lead progressionCYP5122A1, a novel cytochrome P450 is essential for survival of Leishmania donovaniParasitic pneumonia and lung involvementExpression profiling of nuclear receptors in the NCI60 cancer cell panel reveals receptor-drug and receptor-gene interactions.Efficacy of miltefosine for the treatment of American cutaneous leishmaniasis.Antileishmanial and antitrypanosomal activities of the 8-aminoquinoline tafenoquine.In vitro bactericidal activity of the antiprotozoal drug miltefosine against Streptococcus pneumoniae and other pathogenic streptococciAmphiphilic Antimony(V) Complexes for Oral Treatment of Visceral LeishmaniasisAmiodarone and miltefosine act synergistically against Leishmania mexicana and can induce parasitological cure in a murine model of cutaneous leishmaniasis.Drug delivery systems for the topical treatment of cutaneous leishmaniasis.Lingual Leishmaniasis Presenting to Maxillofacial Surgery in UK with Successful Treatment with Miltefosine.Dronedarone, an amiodarone analog with improved anti-Leishmania mexicana efficacy.Distinctive molecular signaling in triple-negative breast cancer cell death triggered by hexadecylphosphocholine (miltefosine).Exome Sequencing Identifies Two Variants of the Alkylglycerol Monooxygenase Gene as a Cause of Relapses in Visceral Leishmaniasis in Children, in Sudan.Combined suboptimal schedules of topical paromomycin, meglumine antimoniate and miltefosine to treat experimental infection caused by Leishmania (Viannia) braziliensis.Phospholipases a in trypanosomatids.Efficacy and tolerability of oleylphosphocholine (OlPC) in a laboratory model of visceral leishmaniasis.Discovery of novel, orally bioavailable, antileishmanial compounds using phenotypic screening.Effects of miltefosine treatment in fibroblast cell cultures and in mice experimentally infected with Neospora caninum tachyzoites.LC-coupled ESI MS for quantification of miltefosine in human and hamster plasma.Why miltefosine-a life-saving drug for leishmaniasis-is unavailable to people who need it the most.
P2860
Q24615049-16A99303-84BE-450E-821A-366AB423D31AQ28088410-B1DE5660-0472-4690-BD29-D327A9A7E69BQ28271849-B4CA58FB-7431-4996-9072-1079B547C426Q28475996-B666ABD4-EC7A-438F-B448-B6B51E39EA3AQ28477209-8210040A-7529-40C4-B6E3-4EFA48A7C216Q33796627-5BC406EE-E29B-4567-A7A2-13971595A90AQ33874365-C2D0C843-4826-4837-970B-B575488D42E0Q34024861-1BB48F19-9514-4487-ABE3-771C7EF6A4AAQ34309401-BAC61DF5-2B93-4613-A169-882EB3ACC259Q35759108-636739EA-C372-4A4D-9D9C-E119B0CDECE0Q37124150-147DD00F-A7F0-4A4B-93CA-FF68FAC1585EQ37450724-D65D45BF-A88B-46C8-B51B-7DC8CE1D23DFQ38020882-49E53EFA-79F2-4C09-9849-7949616CA127Q39122827-A02E7205-5A15-4FD9-82D9-EE03FDD4099DQ39683991-0E09F5D8-9D84-45E3-A567-1D6769F2823EQ39910888-11F326BA-6E67-47F3-88A5-788A11A4A262Q40053798-A3DBE6D1-A8E1-46F0-9BA7-0F27A99E9529Q41011525-E48B18FA-C023-404B-93F9-3BF07C9006C1Q42716413-609B0383-D30B-49FA-AD6C-49D12CFE47EEQ45185252-D08C125E-4764-4D54-AB48-D80ABB2E3303Q48330948-EB381625-A263-4EDD-9FD9-3AC8F4055134Q51362513-17D3300C-71A8-436C-B0AB-5A8C24891E7DQ51738993-60A6BE03-CAFA-4C21-948A-BA8B7665881FQ54961274-9000F4A8-EF9F-4F0A-8845-2F8EF5097C2D
P2860
Miltefosine--discovery of the antileishmanial activity of phospholipid derivatives.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Miltefosine--discovery of the antileishmanial activity of phospholipid derivatives.
@ast
Miltefosine--discovery of the antileishmanial activity of phospholipid derivatives.
@en
type
label
Miltefosine--discovery of the antileishmanial activity of phospholipid derivatives.
@ast
Miltefosine--discovery of the antileishmanial activity of phospholipid derivatives.
@en
prefLabel
Miltefosine--discovery of the antileishmanial activity of phospholipid derivatives.
@ast
Miltefosine--discovery of the antileishmanial activity of phospholipid derivatives.
@en
P2860
P1476
Miltefosine--discovery of the antileishmanial activity of phospholipid derivatives.
@en
P2093
Juergen Engel
Simon L Croft
P2860
P356
10.1016/J.TRSTMH.2006.03.009
P478
100 Suppl 1
P577
2006-08-14T00:00:00Z